EUVIMEDEUVIMED entdecken
Open Access

LiaX is a surrogate marker for cell envelope stress and daptomycin non-susceptibility in Enterococcus faecium

Dierdre B Axell-House, Shelby R Simar, Diana Panesso, Sandra Rincon, William R Miller iD, Ayesha Khan iD, Orville A Pemberton, Lizbet Valdez, April H Nguyen, Kara S Hood, Kirsten Rydell, Andrea M DeTranaltes und 12 weitere

Antimicrobial Agents and Chemotherapy · 2024

DOI: 10.1128/aac.01069-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Dierdre B Axell-House und 23 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA. Hauptthemen laut MEDLINE: Cell Membrane, Daptomycin, Enterococcus faecium, Gram-Positive Bacterial Infections. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, HHS | National Institutes of Health, Houston Methodist Clinical Scholars Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Daptomycin (DAP) is often used as a first-line therapy to treat vancomycin-resistant Enterococcus faecium infections, but emergence of DAP non-susceptibility threatens the effectiveness of this antibiotic. Moreover, current methods to determine DAP minimum inhibitory concentrations (MICs) have poor reproducibility and accuracy. In enterococci, DAP resistance is mediated by the LiaFSR cell membrane stress response system, and deletion of liaR encoding the response regulator results in hypersusceptibility to DAP and antimicrobial peptides. The main genes regulated by LiaR are a cluster of three genes, designated liaXYZ . In Enterococcus faecalis , LiaX is surface-exposed with a C-terminus that functions as a negative regulator of cell membrane remodeling and an N-terminal domain that is released to the extracellular medium where it binds DAP. Thus, in E. faecalis , LiaX functions as a sentinel molecule recognizing DAP and controlling the cell membrane response, but less is known about LiaX in E. faecium . Here, we found that liaX is essential in E. faecium with an activated LiaFSR system. Unlike E. faecalis , E. faecium LiaX is not detected in the extracellular milieu and does not appear to alter phospholipid architecture. We further postulated that LiaX could be used as a surrogate marker for cell envelope activation and non-susceptibility to DAP. For this purpose, we developed and optimized a LiaX enzyme-linked immunosorbent assay (ELISA). We then assessed 86 clinical E. faecium bloodstream isolates for DAP MICs and used whole genome sequencing to assess for substitutions in LiaX. All DAP-resistant clinical strains of E. faecium exhibited elevated LiaX levels. Strikingly, 73% of DAP-susceptible isolates by standard MIC determination also had elevated LiaX ELISAs compared to a well-characterized DAP-susceptible strain. Phylogenetic analyses of predicted amino acid substitutions showed 12 different variants of LiaX without a specific association with DAP MIC or LiaX ELISA values. Our findings also suggest that many E. faecium isolates that test DAP susceptible by standard MIC determination are likely to have an activated cell stress response that may predispose to DAP failure. As LiaX appears to be essential for the cell envelope response to DAP, its detection could prove useful to improve the accuracy of susceptibility testing by anticipating therapeutic failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell MembraneDaptomycinEnterococcus faeciumGram-Positive Bacterial InfectionsHumansAnti-Bacterial AgentsBiomarkersDrug Resistance, BacterialEnterococcus faecalisMicrobial Sensitivity TestsPhylogenyReproducibility of Results

Stichwörter der Autor:innen

Enterococcus faeciumantibiotic resistancedaptomycin

Substanzen

Anti-Bacterial AgentsBiomarkersDaptomycin

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA.
  • Center for Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA.
  • Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
  • Center for Infectious Diseases, University of Texas Health Science Center, School of Public Health, Houston, Texas, USA.
  • Molecular Genetics and Antimicrobial Resistance Unit, Universidad El Bosque, Bogotá, Colombia.
  • Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

ORCID-Profile: William R Miller, Ayesha Khan, Jinnethe Reyes, Samuel A Shelburne, Kavindra V Singh, Yousif Shamoo, Blake M Hanson, Truc T Tran, Cesar A Arias

Förderung

  • NIAID NIH HHS
  • HHS | National Institutes of Health
  • Houston Methodist Clinical Scholars Award

Zitieren

APA

Axell-House, D. B., Simar, S. R., Panesso, D., Rincon, S., Miller, W. R., Khan, A., Pemberton, O. A., Valdez, L., Nguyen, A. H., Hood, K. S., Rydell, K., DeTranaltes, A. M., Jones, M. N., Atterstrom, R., Reyes, J., Sahasrabhojane, P. V., Suleyman, G., Zervos, M., Shelburne, S. A., …, & Arias, C. A. (2024). LiaX is a surrogate marker for cell envelope stress and daptomycin non-susceptibility in Enterococcus faecium. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01069-23

Vancouver

Axell-House DB, Simar SR, Panesso D, Rincon S, Miller WR, Khan A, et al. LiaX is a surrogate marker for cell envelope stress and daptomycin non-susceptibility in Enterococcus faecium. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.01069-23

BibTeX
@article{AxellHouse2024,
  author = {Axell-House, Dierdre B and Simar, Shelby R and Panesso, Diana and Rincon, Sandra and Miller, William R and Khan, Ayesha and Pemberton, Orville A and Valdez, Lizbet and Nguyen, April H and Hood, Kara S and Rydell, Kirsten and DeTranaltes, Andrea M and Jones, Mary N and Atterstrom, Rachel and Reyes, Jinnethe and Sahasrabhojane, Pranoti V and Suleyman, Geehan and Zervos, Marcus and Shelburne, Samuel A and Singh, Kavindra V and Shamoo, Yousif and Hanson, Blake M and Tran, Truc T and Arias, Cesar A},
  title = {LiaX is a surrogate marker for cell envelope stress and daptomycin non-susceptibility in Enterococcus faecium},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  doi = {10.1128/aac.01069-23}
}
Kostenlos starten →